Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-24 @ 2:07 PM
NCT ID:
NCT00573495
Eligibility Criteria:
Inclusion Criteria:
* Stage IV breast cancer that has failed at least one conventional therapy for metastatic disease
* HLA-A2 positive
* Measurable or evaluable disease
* ECOG performance status 0-1
* Negative contrast CT or MRI scan of the brain within 30 days of treatment
* Negative pregnancy test within 14 days of treatment for women of childbearing potential
Exclusion Criteria:
* History of brain metastases within the last 4 years
* The use of chemotherapy, radiation therapy, immunosuppressive drugs, systemic glucocorticoids, growth factors, or experimental therapy, and anti-coagulants within 14 days prior to treatment
* Initiation of hormonal agent in the 30 days before treatment
* Initiation of Herceptin in the 30 days prior to treatment.
* History of bone marrow or stem cell transplantation
* Pregnant or lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00573495
Study Brief:
Protocol Section:
NCT00573495